Experience with Timoptic in Patients with Open-angle and Narrow-angle Glaucoma.
- Author:
Jae Ho KIM
1
;
Ha Bum LEE
Author Information
1. Dept. of Ophthalmology St. Mary's Hospital, Catholic Medical College, Seoul, Korea.
- Publication Type:Original Article
- MeSH:
Acetazolamide;
Glaucoma, Angle-Closure*;
Glaucoma, Open-Angle;
Humans;
Hyperemia;
Intraocular Pressure;
Miosis;
Ocular Hypertension;
Timolol*
- From:Journal of the Korean Ophthalmological Society
1979;20(4):527-531
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Total eight patients(12 eyes) who are suffering from chronic open-angle glaoucoma(7 eyes), Chronic narrow-angle glaucoma (3 eyes) and ocular hypertension (2 eyes) were treated topically with 0.25~0.5% Timoptic ophthalmic solution (Timolol maleate/MSD), and were observed clinically for various periods ranging from 14 days to 120 days. Results are summerized as follows; 1. Timoptic ophthalmic solution is a new effective eye drop to lowering intraocular pressure in patients of open-angle glaucoma and ocular hypertension. We re-comformed its effectiveness on intraocular pressure in Korean glaueoma patients. And its average range for the decrease of intraocular pressure was 8 mmHg (5~12mm Hg). 2. In Chronic narrow-angle glaucoma patients, Timoptic Opthalmic solution could be decreased effectivey intraocular pressure as such as open-angle glaucoma patients. 3. Any other complications such as miosis. irritative hyperemia or tearing etc. were not found during the observation period. 4. In uneffective patients with Timoptic alone, other antiglaucoma agents (pilo., Diamox etc) could be used additively with combination of Timoptic.
